Yi Arial Zeng

5.4k citations
82 papers · 3.3k indexed · 1 hit paper · h-index 27
Topics
Wnt/β-catenin signaling in development and cancer (17 papers)Cancer Cells and Metastasis (16 papers)Pancreatic function and diabetes (8 papers)

In The Last Decade

Yi Arial Zeng

79 papers receiving 3.3k citations

Hit Papers

Organoids20222026202320242022100200300400500

Peers

Yi Arial Zeng
Comparison fields: 5 of 141
  • Molecular Biology 1.7k
  • Oncology 938
  • Immunology 447
  • Surgery 410
  • Cancer Research 369
Replace Hugo Vankelecom with:
Hugo Vankelecom Belgium
Orest W. Blaschuk Canada
Ludwig Wagner Austria
Martin Fischer Germany
Yujiro Tanaka Japan
Murim Choi South Korea
Takashi Nakajima Japan
Andrea Brendolan Italy
Hua Tian China
Tiziana Crepaldi Italy
Yi Arial Zeng relative to Hugo Vankelecom Belgium Hugo Vankelecom's profile →
Citations per field
00.5×1.5×1.8×
Hugo Vankelecom · 1×
Citations per year

Countries citing papers authored by Yi Arial Zeng

Since Specialization
Citations

This map shows the geographic impact of Yi Arial Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Arial Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Arial Zeng more than expected).

Fields of papers citing papers by Yi Arial Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Arial Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Arial Zeng. The network helps show where Yi Arial Zeng may publish in the future.

Co-authorship network of co-authors of Yi Arial Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Arial Zeng. A scholar is included among the top collaborators of Yi Arial Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Arial Zeng. Yi Arial Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 14
4 7
5 26
6 10
7 12
8 12
9 24
10 5
11 76
12 82
13 78
14 12
15 4
16 17
17 1
18 1
19 14
20 48

About Yi Arial Zeng

Yi Arial Zeng is a scholar working on Developmental Neuroscience, Oncology and Immunology, having authored 82 papers that have together received 3.3k indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (17 papers), Cancer Cells and Metastasis (16 papers) and Pancreatic function and diabetes (8 papers). The work is most often cited by research in Oncology (938 citations), Developmental Neuroscience (105 citations) and Molecular Biology (1.7k citations). Yi Arial Zeng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Roel Nusse, Qing Yu, Daisong Wang, Esther M. Verheyen, Cheguo Cai, Xiaobing Dong, Wenqian Song, Li Yang, Aleksandra Sljukic and Meritxell Huch. Their work appears in journals such as Nature, Cell and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026